Evidence map›Paper›PMID 39225843›Full record

ArticleDiscover oncology2024

Diversity in gut microbiota among colorectal cancer patients: findings from a case-control study conducted at a Tunisian University Hospital.

Mariem Zrelli, Asma Ferjani, Mariem Nouira, Sirine Hammami, Nadine Ghithia, Leila Mouelhi, Radhouane Debbeche, Didier Raoult, Ilhem Boutiba Ben Boubaker

Abstract read
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mariem ZrelliFaculty of Medicine of Tunis, Research Laboratory ''Antimicrobial Resistance'' LR99ES09, University of Tunis El Manar, 1007, Tunis, Tunisia. zrelli.myriam@gmail.com.
Asma FerjaniFaculty of Medicine of Tunis, Research Laboratory ''Antimicrobial Resistance'' LR99ES09, University of Tunis El Manar, 1007, Tunis, Tunisia.
Mariem NouiraEpidemiology Department, Charles Nicolle Hospital, Faculty of Medicine of Tunis, University of Tunis El Manar, 1006, Tunis, Tunisia.
Sirine HammamiDepartment of Gastroenterology, Charles Nicolle Hospital, 1006, Tunis, Tunisia.
Nadine GhithiaDepartment of Gastroenterology, Charles Nicolle Hospital, 1006, Tunis, Tunisia.
Leila MouelhiDepartment of Gastroenterology, Charles Nicolle Hospital, 1006, Tunis, Tunisia.
Radhouane DebbecheDepartment of Gastroenterology, Charles Nicolle Hospital, 1006, Tunis, Tunisia.
Didier RaoultIRD, APHM, MEPHI, Aix Marseille Univ, 19-21 Boulevard Jean Moulin, 13005, Marseille, France. didier.raoult@gmail.com.
Ilhem Boutiba Ben BoubakerFaculty of Medicine of Tunis, Research Laboratory ''Antimicrobial Resistance'' LR99ES09, University of Tunis El Manar, 1007, Tunis, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGlobally, colorectal cancer (CRC) is among the most prevalent cancers. One distinctive feature of colorectal cancer is its close relationship to the gut microbiota, which is a crucial component of the tumor microenvironment. Over the last ten years, research has demonstrated that colorectal cancer is accompanied with dysbiosis of gut bacteria, fungi, viruses, and Archaea, and that these alterations may be causal.

objectivesThis study aimed to evaluate the disruption of the microorganism composition in the intestine, especially bacteria and to determine their relationship with colorectal cancer.

methodsAn evaluation system for determining colorectal cancer (CRC) risk and prognosis can be established more easily with the help of accurate gut microbiota profiling. Stool samples from 14 CRC patients and 13 controls were collected and the flora relative abundance was measured using targeted quantitative PCR (qPCR) assays to evaluate diagnostic potential of selected biomarkers: Streptococcus gallolyticus and Enterococcus faecalis. Culture and MALDI-TOF mass spectrometry were coupled to identify the gut microbiota in both colorectal cancer and control groups.

resultsCompared with controls, the gut microbiota of CRC patients showed an increase in the abundance of Enterococcus, Fusobacterium and Streptococcus. At the species level, the CRC enriched bacterium including Escherichia coli, Enterococcus faecalis, Fusobacterium nucleatum, Streptococcus gallolyticus, Flavoni fractorplautii and Eggerthella lenta acted as promising biomarkers for early detection of CRC.

conclusionThis study highlights the potential of gut microbiota biomarkers as a promising non-invasive tool for the accurate detection and distinction of individuals with CRC.

Indexed as

Colorectal cancerCulturomicsGut microbiotaMALDI TOF mass spectrometryRisk factors

Identifiers

PMID39225843
PMCPMC11372012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.